The Journal of Infectious Diseases
-
Publication Venue For
-
Socio-demographic variables can guide prioritized testing strategies for epidemic control in resource-limited contexts..
jiad076.
2023
-
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy
2020
-
Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients..
222:1798-1806.
2020
-
ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus Infection..
220:203-212.
2019
-
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes..
218:946-955.
2018
-
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected Patients..
218:814-824.
2018
-
Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution..
216:604-611.
2017
-
Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey..
216:36-44.
2017
-
Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil..
216:172-181.
2017
-
Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection..
215:42-51.
2017
-
Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+
T-Cell Activation.
213:569-573.
2016
-
A Systematic Review and Meta-Analysis of the Seroprevalence of Influenza A(H9N2) Infection Among Humans..
212:562-569.
2015
-
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection..
211:1925-1935.
2015
-
CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination..
210 Suppl 3:S641-S647.
2014
-
Vaccine-Associated Paralytic Poliomyelitis in the Postelimination Era in Latin America and the Caribbean, 1992–2011.
209:1393-1402.
2014
-
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection..
205:1147-1154.
2012
-
Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection..
205:1248-1257.
2012
-
Reply to gould.
205:865.
2012
-
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials..
203:969-975.
2011
-
Divergent Mechanisms for Passive Pneumococcal Resistance to β-Lactam Antibiotics in the Presence of Haemophilus influenzae.
203:549-555.
2011
-
Coinfection withHaemophilus influenzae
Promotes Pneumococcal Biofilm Formation during Experimental Otitis Media and Impedes the Progression of Pneumococcal Disease.
202:1068-1075.
2010
-
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine..
200:1068-1077.
2009
-
Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?.
200:5-7.
2009
-
Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States..
199:1081-1086.
2009
-
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years..
199:926-935.
2009
-
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years..
199:936-944.
2009
-
Streptococcus pneumoniae
Forms Surface‐Attached Communities in the Middle Ear of Experimentally Infected Chinchillas.
199:786-794.
2009
-
Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model..
199:201-208.
2009
-
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses..
198:1514-1519.
2008
-
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial..
198:1309-1316.
2008
-
Mice that overexpress CC chemokine ligand 2 in their lungs show increased protective immunity to infection with Mycobacterium bovis bacille Calmette-Guérin..
198:1044-1054.
2008
-
Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations..
198:602-608.
2008
-
The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population..
198:90-94.
2008
-
HIV and the kidney: a spotlight on racial disparities..
197:1490-1492.
2008
-
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine..
197:825-835.
2008
-
Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents..
197:752-756.
2008
-
The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine..
197 Suppl 2:S207-S215.
2008
-
Vaccination against Herpes Zoster and Postherpetic Neuralgia..
197 Suppl 2:S228-S236.
2008
-
Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation..
197:283-291.
2008
-
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates..
197:163-171.
2008
-
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection..
196:1438-1446.
2007
-
Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis..
196:1425-1430.
2007
-
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s)..
196:835-843.
2007
-
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection..
196:738-747.
2007
-
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170..
195:1426-1436.
2007
-
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease..
195:980-988.
2007
-
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses..
195:826-832.
2007
-
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality..
195:756-764.
2007
-
Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment..
195:511-518.
2007
-
Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines..
194:1625-1627.
2006
-
ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations..
194:795-803.
2006
-
Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity..
194:751-759.
2006
-
HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses..
194:168-175.
2006
-
Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia..
193:1384-1393.
2006
-
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial..
193:27-35.
2006
-
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women..
192:2129-2133.
2005
-
Intermittent preventive treatment for malaria in infants: moving forward, cautiously..
192:1869-1871.
2005
-
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection..
192:1731-1740.
2005
-
Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease..
192:1757-1766.
2005
-
Reply to Rodríguez‐Morales et al..
192:1676-1677.
2005
-
White blood cell counts in Plasmodium vivax malaria..
192:1675-1676.
2005
-
A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients..
192:1349-1354.
2005
-
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects..
192:1249-1259.
2005
-
Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa..
192:888-892.
2005
-
Appropriate use of nevirapine for long-term therapy..
192:545-546.
2005
-
White blood cell counts and malaria..
192:323-330.
2005
-
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012..
192:24-29.
2005
-
Impaired systemic production of prostaglandin E2 in children with cerebral malaria..
191:1548-1557.
2005
-
The effect of increasing age on the risk of surgical site infection..
191:1056-1062.
2005
-
Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects..
191:825-829.
2005
-
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines..
190:1962-1969.
2004
-
Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells..
190:1692-1696.
2004
-
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein..
190:1140-1149.
2004
-
Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody..
190:856-865.
2004
-
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies..
189:2167-2173.
2004
-
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS..
189:1793-1801.
2004
-
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients..
189:1615-1618.
2004
-
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein..
189:1221-1231.
2004
-
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV..
189:1075-1083.
2004
-
Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection..
188:1461-1472.
2003
-
Epidemiology of bloodstream infections in a bacille Calmette-Guérin-vaccinated pediatric population in Malawi..
188:202-208.
2003
-
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control..
187:1027-1037.
2003
-
Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States..
187:866-868.
2003
-
Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children..
187:385-397.
2003
-
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis..
186:1013-1018.
2002
-
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316..
186:181-188.
2002
-
Identification and evolution of an IS6110 low-copy-number Mycobacterium tuberculosis cluster..
185:641-649.
2002
-
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure..
185:428-438.
2002
-
Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin..
184:1603-1607.
2001
-
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease..
184:940-943.
2001
-
Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria..
184:330-336.
2001
-
Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection..
184:127-135.
2001
-
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant..
183:1688-1693.
2001
-
Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy..
183:1522-1525.
2001
-
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers..
183:1343-1352.
2001
-
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine..
183:1116-1120.
2001
-
The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings..
183:1063-1070.
2001
-
Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis..
183 Suppl 1:S51-S55.
2001
-
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients..
183:579-588.
2001
-
Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria..
183:113-118.
2001
-
Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women..
182:1365-1374.
2000
-
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children..
182:1385-1393.
2000
-
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease..
182:1183-1191.
2000
-
In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source..
182:1251-1254.
2000
-
Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia..
182:1255-1259.
2000
-
Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity..
182:988-992.
2000
-
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus..
182:28-35.
2000
-
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults..
182:326-329.
2000
-
Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs..
181:1791-1795.
2000
-
A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy..
181:1414-1420.
2000
-
Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention..
181:1428-1434.
2000
-
Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity..
181:897-903.
2000
-
Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection..
181:812-813.
2000
-
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine..
180:2018-2022.
1999
-
Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria..
180:1994-2002.
1999
-
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine..
180:1757-1762.
1999
-
Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study..
180:1536-1541.
1999
-
Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men..
180:1245-1251.
1999
-
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women..
180:1080-1088.
1999
-
The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina..
180:900-903.
1999
-
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers..
180:290-298.
1999
-
Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization..
180:534-537.
1999
-
Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/=15 years old, Bangkok..
180:87-92.
1999
-
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina..
180:99-105.
1999
-
Malaria infection during pregnancy: intrauterine growth retardation and preterm delivery in Malawi..
179:1580-1583.
1999
-
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors..
179:1264-1267.
1999
-
Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients..
179:1157-1161.
1999
-
Meningococcal disease outbreak associated with disco attendance..
179:751-752.
1999
-
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group..
179:59-67.
1999
-
Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment..
178:1803-1805.
1998
-
Racial and psychosocial risk factors for herpes zoster in the elderly..
178 Suppl 1:S67-S70.
1998
-
Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042..
178:1170-1173.
1998
-
Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection..
178:776-782.
1998
-
Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection..
178:243-246.
1998
-
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group..
177:1230-1246.
1998
-
Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection..
177:1247-1259.
1998
-
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group..
177:301-309.
1998
-
A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection..
177:231-234.
1998
-
Cytokines in murine lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain..
177:242-246.
1998
-
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection..
176:924-932.
1997
-
Assessment of similarity among coagulase-negative staphylococci from sequential blood cultures of neonates and children by pulsed-field gel electrophoresis..
174:1010-1014.
1996
-
Pathogenic Escherichia coli in children with and without chronic diarrhea in Tanzania..
174:675-677.
1996
-
Racial differences in herpes zoster and age at onset of varicella..
174:239-241.
1996
-
Reply.
174:240-241.
1996
-
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes..
173:849-856.
1996
-
Acyclovir in human immunodeficiency virus patients..
173:504-507.
1996
-
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors..
173:60-67.
1996
-
Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication..
172:964-973.
1995
-
Expression of a murine cytomegalovirus early-late protein in "latently" infected mice..
172:371-379.
1995
-
Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland..
172:531-534.
1995
-
Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization..
172:217-219.
1995
-
Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene..
171:1623-1627.
1995
-
Racial differences in the occurrence of herpes zoster..
171:701-704.
1995
-
Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study..
170:1284-1287.
1994
-
Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine..
170:1050-1051.
1994
-
CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group..
170:775-781.
1994
-
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network..
170:782-786.
1994
-
Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity..
170:60-67.
1994
-
Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine..
170:51-59.
1994
-
Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae..
169:859-867.
1994
-
Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group..
169:893-897.
1994
-
Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development..
169:532-537.
1994
-
Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions..
169:305-312.
1994
-
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network..
168:1387-1395.
1993
-
Human immunodeficiency virus type 1 infection of human monocytes and macrophages does not alter their ability to generate an oxidative burst..
168:459-462.
1993
-
Distribution of Haemophilus influenzae type b outer membrane protein subtypes in different ethnic groups in Australia..
168:255.
1993
-
Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice..
167:950-954.
1993
-
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network..
167:533-537.
1993
-
Aging and reactivation of latent murine cytomegalovirus..
166:1403-1407.
1992
-
Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users..
166:896-899.
1992
-
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network..
166:244-252.
1992
-
Haemophilus influenzae type b infections in Victoria, Australia, 1985-1989..
165 Suppl 1:S33-S34.
1992
-
Socioeconomic risk factors for invasive Haemophilus influenzae type b disease..
165 Suppl 1:S11-S15.
1992
-
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients..
165:891-897.
1992
-
Prophylaxis of cytomegalovirus disease in allogeneic bone marrow transplantation..
165:972-973.
1992
-
Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up..
164:818.
1991
-
Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants..
164:792-796.
1991
-
Balantidium coli infestation as a cause of acute appendicitis..
163:1392.
1991
-
Fatal Queensland tick typhus..
162:779-780.
1990
-
Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system..
162:201-207.
1990
-
Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease..
161:1068-1072.
1990
-
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence..
161:1153-1169.
1990
-
Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes..
161:692-698.
1990
-
Amphotericin B-induced malignant hypertensive episodes..
161:588.
1990
-
Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification..
161:220-225.
1990
-
Cryptococcal meningitis with normal cerebrospinal fluid..
160:912.
1989
-
Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA..
160:460-468.
1989
-
Deferoxamine treatment as a risk factor for zygomycete infection..
159:151-152.
1989
-
Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis..
158:588-595.
1988
-
Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany..
157:1014-1022.
1988
-
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe..
157:743-748.
1988
-
Hepatitis B vaccines in patients with chronic renal failure before dialysis..
157:332-337.
1988
-
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells..
156:316-323.
1987
-
Influence of trimethoprim and sulfamethoxazole on the synthesis, expression, and function of type 1 fimbriae of Escherichia coli..
154:490-496.
1986
-
Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli..
153:547-551.
1986
-
Infection with varicella-zoster virus after marrow transplantation..
152:1172-1181.
1985
-
The source of murine cytomegalovirus in mice receiving kidney allografts..
152:1192-1196.
1985
-
Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster..
151:355-361.
1985
-
Toxocara canis infection: clinical and epidemiological associations with seropositivity in kindergarten children..
149:591-597.
1984
-
Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study..
148:551-556.
1983
-
Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile..
147:733-736.
1983
-
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli..
147:514-522.
1983
-
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole..
146:429-435.
1982
-
Selective antimicrobial modulation of human microbial flora..
145:427-429.
1982
-
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration..
145:160-168.
1982
-
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh..
142:660-664.
1980
-
Increase in antibiotic resistance among isolates of Salmonella in the United States, 1967-1975..
142:485-491.
1980
-
Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline..
141:702-711.
1980
-
Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria..
138:359-368.
1978
-
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent..
136:187-195.
1977
-
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests..
136:196-204.
1977
-
Food-borne botulism in the United States, 1970-1975..
136:153-159.
1977
-
From the Center for Disease Control: salmonellosis in the United States, 1968-1974..
133:483-486.
1976
-
Outbreaks of waterborne disease in the United States, 1973..
132:336-339.
1975
-
From the center for disease control..
132:224-228.
1975
-
Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice..
131:129-137.
1975
-
Influenza research in the Soviet Union--1974..
130:686-693.
1974
-
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media..
130:454-463.
1974
-
Surveillance of foodborne disease in the United States, 1971-1972..
129:365-368.
1974
-
Outbreaks of waterbone disease in the United States, 1971-1972.
129:614-615.
1974
-
Cefazolin in the treatment of bacterial pneumonia..
128:Suppl:S382-5.
1973
-
Exposure to hyperbaric oxygen not beneficial for murine tetanus..
128:238-242.
1973
-
Activation of complement by endotoxin..
128:Suppl:86-90.
1973
-
Bactericidal antibody after colonization with Neisseria meningitidis..
127:56-62.
1973
-
Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus..
126:207-209.
1972
-
Humoral mediators of chemotaxis of mononuclear leukocytes..
125:595-602.
1972
-
Experimental effects of hyperbaric oxgen on selected clostridial species. I. In-vitro studies..
125:17-25.
1972
-
Experimental effects of hyperbaric oxygen on selected clostridial species. II. In-vitro studies in mice..
125:26-35.
1972
-
Periodontal disease: a model for the study of inflammation..
123:676-677.
1971
-
Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969..
122:181-190.
1970
-
Shigellosis among Indians..
121:355-357.
1970
-
Neisseria meningitidis, a respiratory pathogen?.
121:48-54.
1970
-
From the national communicable disease center. Shigellosis in the United States. 1964-1968..
120:393-396.
1969
-
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120..
183:563-570.
2001
-
Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
2005